The Evolution Of Crisis Response Systems: An OPEN MINDS Roundtable On Harris County's Collaborative CORE Model is starting in

Antipsychotic Drug Use Increases Risk Of Mortality Among Persons With Alzheimer’s Disease

Mortality rates are about 1.6 times higher among people diagnosed with Alzheimer’s disease who were taking antipsychotic medications compared to those with Alzheimer’s who do not take antipsychotics. Antipsychotic polypharmacy nearly tripled the risk of death compared to people taking just one antipsychotic.

These findings were reported in “Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer’s Disease” by Marjaana Koponen, Heidia Taipale, Piiaa Lavikainen, and colleagues. The researchers analyzed data from a nationwide register-based MEDALZ study that included all 70,718 community-dwelling individuals in Finland who were . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: